| Literature DB >> 32034808 |
Guoye Liu1, Rui Xia1, Qian Wang1, Zhiqiang Wang1, Binwu Ying2, Hong Yan1.
Abstract
BACKGROUND: Tuberculosis remains an important disease threatening the security of public health, and no effective targets have been found for the immunological diagnosis or therapy of tuberculosis. The aim of this study was to explore the associations between lncRNA CASC8 genetic polymorphism and tuberculosis risk.Entities:
Keywords: LncRNA CASC8; single nucleotide polymorphism (SNP); tuberculosis susceptibility
Mesh:
Substances:
Year: 2020 PMID: 32034808 PMCID: PMC7307370 DOI: 10.1002/jcla.23234
Source DB: PubMed Journal: J Clin Lab Anal ISSN: 0887-8013 Impact factor: 2.352
Figure 1Differentially expressed LncRNA CASC8 between ATB and control group. High relative expression was indicated by red color, and low relative expression was indicated by blue color
Demographic characteristics of participants in Chinese Han population
| Features | TB (n = 900) | HC (n = 1534) |
|
|---|---|---|---|
| General information | |||
| Age, mean ± SD (y) | 42.51 ± 18.11 | 37.96 ± 11.07 |
|
| Male (%) | 542 (60.22%) | 821 (53.52%) |
|
| TB clinical subtype n (%) | |||
| PTB | 657 (73.0) | ||
| EPTB | 93 (10.3) | ||
| PTB & EPTB | 150 (16.7) | ||
Abbreviations: EPTB, extra‐pulmonary tuberculosis; HC, healthy controls; PTB & EPTB, pulmonary tuberculosis combined with extra‐pulmonary tuberculosis; PTB, pulmonary tuberculosis; TB, tuberculosis.
Bold indicates statistical significant value.
Genetic polymorphisms of CASC8 in patients with TB
| SNP | Variant | Case, n (%) | Control, n (%) | OR (95%CI) |
|
| Variant | Case, n (%) | Control, n (%) |
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| rs7825118 | A | 413 (22.94) | 739 (24.09) | 0.9366 (0.82‐1.08) | .3508 | – | AA | 47 (5.22) | 89 (5.8) | .2446 | .9266 |
| G>A | G | 1379 (76.61) | 2311 (75.33) | AG | 319 (35.44) | 561 (36.57) | |||||
| GG | 530 (58.89) | 875 (57.04) | |||||||||
| rs6981424 | A | 418 (23.22) | 666 (21.71) | 1.087 (0.95‐1.25) | .2399 | .9595 | AA | 48 (5.33) | 69 (4.5) | .2316 | .9785 |
| G>A | G | 1380 (76.67) | 2390 (77.9) | AG | 322 (35.78) | 528 (34.42) | |||||
| GG | 529 (58.78) | 931 (60.69) | |||||||||
| rs9297758 | A | 680 (37.78) | 1193 (38.89) | 0.957 (0.85‐1.08) | .4724 | – | AA | 130 (14.44) | 223 (14.54) | .3638 | – |
| G>A | G | 1112 (61.78) | 1867 (60.85) | AG | 420 (46.67) | 747 (48.7) | |||||
| GG | 346 (38.44) | 560 (36.51) | |||||||||
| rs7836840 | C | 825 (45.83) | 1309 (42.67) | 1.135 (1.01‐1.28) |
| .1341 | CC | 178 (19.78) | 279 (18.19) |
| .1909 |
| A>C | A | 973 (54.06) | 1753 (57.14) | CA | 469 (52.11) | 751 (48.96) | |||||
| AA | 252 (28) | 501 (32.66) |
Abbreviations: OR, odds ratio; P**, P value after Bonferroni correction; P*, P value after adjusting for gender and age; SNP, single nucleotide polymorphism.
Bold indicates statistical significant value.
Analysis of CASC8 gene polymorphisms relevant to TB risk in Chinese Han population
| SNP | Dominant model | Recessive model | ||||
|---|---|---|---|---|---|---|
| OR (95% CI) |
|
| OR (95% CI) |
|
| |
| rs7825118 G>A | 0.901 (0.76‐1.068) | .2305 | .9218 | 0.9159 (0.6338‐1.324) | .6401 | |
| rs6981424 G>A | 1.095 (0.9237‐1.298) | .2957 | – | 1.189 (0.8095‐1.746) | .3776 | |
| rs9297758 G>A | 0.9089 (0.7649‐1.08) | .2777 | – | 0.9677 (0.7631‐1.227) | .7867 | |
| rs7836840 A>C | 1.236 (1.029‐1.483) |
| .09342 | 1.095 (0.8853‐1.354) | .4033 | |
Bold indicates statistical significant value.
Genetic polymorphisms of CASC8 in patients with PTB
| SNP | Variant | Case, n (%) | Control, n (%) | OR (95%CI) |
|
| Variant | Case, n (%) | Control, n (%) |
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| rs7825118 | A | 285 (21.69) | 739 (24.09) | 0.8729 (0.7474‐1.02) | .08605 | .3442 | AA | 28 (4.26) | 89 (5.8) |
| .1834 |
| G>A | G | 1021 (77.7) | 2311 (75.33) | AG | 229 (34.86) | 561 (36.57) | |||||
| GG | 396 (60.27) | 875 (57.04) | |||||||||
| rs6981424 | A | 301 (22.91) | 666 (21.71) | 1.068 (0.9153‐1.247) | .4018 | – | AA | 32 (4.87) | 69 (4.5) | .4305 | – |
| G>A | G | 1011 (76.94) | 2390 (77.9) | AG | 237 (36.07) | 528 (34.42) | |||||
| GG | 387 (58.9) | 931 (60.69) | |||||||||
| rs9297758 | A | 475 (36.15) | 1193 (38.89) | 0.8945 (0.7823‐1.023) | .1033 | .4132 | AA | 86 (13.09) | 223 (14.54) | .06532 | .2613 |
| G>A | G | 831 (63.24) | 1867 (60.85) | AG | 303 (46.12) | 747 (48.7) | |||||
| GG | 264 (40.18) | 560 (36.51) | |||||||||
| rs7836840 | C | 619 (47.11) | 1309 (42.67) | 1.196 (1.05‐1.362) |
|
| CC | 138 (21) | 279 (18.19) |
| .05013 |
| A>C | A | 693 (52.74) | 1753 (57.14) | CA | 343 (52.21) | 751 (48.96) | |||||
| AA | 175 (26.64) | 501 (32.66) |
Abbreviations: OR, odds ratio; P**, P value after Bonferroni correction; P*, P value after adjusting for gender and age; SNP, single nucleotide polymorphism.
Bold indicates statistical significant value.
Analysis of CASC8 gene polymorphisms relevant to PTB risk in Chinese Han population
| SNP | Dominant model | Recessive model | ||||
|---|---|---|---|---|---|---|
| OR (95% CI) |
|
| OR (95% CI) |
|
| |
| rs7825118 G>A | 0.8344 (0.6886‐1.011) | .06477 | .2591 | 0.755 (0.4847‐1.176) | .2138 | – |
| rs6981424 G>A | 1.089 (0.9002‐1.318) | .3795 | – | 1.032 (0.6636‐1.606) | .888 | – |
| rs9297758 G>A | 0.8417 (0.6945‐1.02) | .07908 | .3163 | 0.8503 (0.6463‐1.119) | .2464 | – |
| rs7836840 A>C | 1.327 (1.078‐1.633) |
|
| 1.167 (0.9231‐1.474) | .1972 | – |
Bold indicates statistical significant value.
Figure 2Linkage disequilibrium (LD) plot of 4 SNPs of LincRNA CASC8. Strong LD is represented by a higher percentage and a darker square
Haplotypes analysis of CASC8 gene associated with the risk of TB
| Haplotype | Frequency | OR (95% CI) |
| ||
|---|---|---|---|---|---|
| All | Case | Control | |||
| GGG | 0.391 | 0.389 | 0.393 | 0.989 (0.877‐1.114) | .8505 |
| AGA | 0.237 | 0.231 | 0.241 | 0.942 (0.821‐1.081) | .3946 |
| GAG | 0.223 | 0.232 | 0.218 | 1.088 (0.946‐1.251) | .2363 |
| GGA | 0.148 | 0.148 | 0.149 | 0.991 (0.841‐1.168) | .9146 |
Figure 3The level of clinical indicators in relation to polymorphisms of CASC8 in TB patients. A refers to serum Hb levels in relation to rs7825118 (G>A), B refers to serum Neu accounts in relation to rs9297758 (G>A), C refers to hepatic enzyme activity in relation to rs6981424 (G>A). Genotype was stratified on the basis of the dominant model, AA+AG vs GG